Vitamin K is easy to misunderstand. One form helps blood clot normally; another is often advertised as a way to put calcium into bones rather than arteries. The biochemistry behind those claims is real. The promised clinical outcomes are a separate question. Here is what we know, where the evidence stops, and why some familiar vitamin-K numbers are misleading.

Key takeaway. Vitamin K1 and the K2 family share a biochemical function, but they are not interchangeable labels for proven health benefits. Most people can obtain enough vitamin K from food. The claim that extra K2 prevents heart disease has not been established by convincing clinical-outcome trials.

What does vitamin K actually do?

Vitamin K is required by an enzyme that activates certain proteins through gamma-carboxylation. These include blood-clotting factors and proteins involved in bone and vascular biology. Without enough vitamin K, normal clotting becomes impaired. That is a demonstrated human function, not a supplement-industry hypothesis.

Some vitamin-K-dependent proteins, including matrix Gla protein (MGP), are involved in the regulation of mineralisation. That helps explain why researchers study vitamin K2 and arterial calcification. But a molecule’s role in a pathway does not mean extra tablets will reduce heart attacks or cause calcium to move from arteries to bones.

Vitamin K1 (phylloquinone) is found mainly in leafy greens and is the principal vitamin-K form in many diets. Vitamin K2 is a family of menaquinones, labelled MK-4, MK-7, MK-9 and so on, with different side-chain lengths and different absorption and distribution profiles.

Long-chain menaquinones are produced by bacteria and can occur in fermented foods and the gut. Critically, the body can make MK-4 from K1 by a pathway that does not require gut bacteria. The older explanation in this article incorrectly portrayed intestinal bacteria as the established machinery that simply converts dietary K1 into absorbable K2.

Gut microbes do make menaquinones, but the extent to which their production reliably contributes to human nutritional vitamin-K status remains uncertain. It cannot be assumed that a healthy gut supplies whatever K2 a person needs.

How much vitamin K do adults need?

In the United States, the dietary reference value is an Adequate Intake (AI), not a Recommended Dietary Allowance (RDA). Researchers could not establish an Estimated Average Requirement from the available evidence, so the AI is based largely on observed intakes among healthy people.

  • Men aged 19 and over: 120 micrograms (µg) per day of total vitamin K (US AI).
  • Women aged 19 and over: 90 µg per day of total vitamin K (US AI).
  • No separate evidence-based daily target for K2: these AIs are not an instruction to obtain 120 or 90 µg of MK-7 specifically.

An AI is not a bright-line threshold below which deficiency suddenly begins. National reference values may also differ. In particular, the figures above should not be used as individual treatment targets for people taking vitamin-K-antagonist medication.

Food sources: check the serving size before trusting the number

The following examples use the US National Institutes of Health Office of Dietary Supplements table. They refer to defined servings, not vaguely described “cups” or estimates extrapolated from dry weight:

  • Spinach, raw, 1 cup: about 145 µg of K1.
  • Kale, raw, 1 cup: about 113 µg of K1, not the 470 µg stated in the former version of this article.
  • Broccoli, boiled, chopped, ½ cup: about 110 µg of K1.
  • Natto, 3 oz (about 85 g): about 850 µg of K2 as MK-7.
  • One large hard-boiled egg: about 4 µg of K2 as MK-4.

The precise amount varies by the food, preparation, analytical method and serving size. The K2 composition of cheeses and other fermented foods is especially variable. The original list of cheese, egg-yolk and liver doses gave an unwarranted impression of precision and implied that a general vitamin-K AI must be met through K2 foods alone; that is incorrect.

Illustration of foods supplying vitamin K1; quantities vary by portion and preparation

Illustration from the original article. For quantitative intake decisions, use the NIH serving-specific data above rather than reading amounts from an illustration.

Is the legendary ‘Activator X’ vitamin K2?

In the early twentieth century, dentist Weston A. Price described a fat-soluble factor he called Activator X in certain animal foods. Later writers have proposed that it was primarily vitamin K2, especially MK-4. This is a retrospective interpretation, not a conclusive identification from a preserved chemical sample.

It is a historically interesting idea, but the inference matters: foods thought to contain the unidentified factor, modern knowledge of vitamin K2 and parallels in bone biology do not by themselves demonstrate that Price’s observations established a vitamin-K2 treatment effect.

Illustration of vitamin K2 food sources; amounts depend on fermentation and food composition

Original illustration of K2-associated foods. Individual menaquinone concentrations and bioavailability vary considerably.

What does supplementation actually accomplish?

The strongest clinical role for vitamin K is prevention and correction of deficiency, including the established use of vitamin K for newborns to prevent vitamin K deficiency bleeding. Newborns have low vitamin-K stores, limited transfer across the placenta and additional risk factors. This is distinct from speculative claims about longevity.

For generally well-nourished adults, claims that K2 supplements reduce arterial calcification, improve bone outcomes or prevent cardiovascular events require trials measuring those endpoints. A mechanism, a blood biomarker or a change in vascular protein activity is not enough. Current evidence does not justify telling everyone to take MK-7 to protect their arteries.

That is not proof that K2 can never have an additional benefit. It means that the size, populations and clinical importance of any benefit remain uncertain. Studies also differ in the form and dose of vitamin K, baseline nutritional status and the outcomes selected.

Vitamin D, calcium and magnesium: the synergy claim needs limits

Vitamin D influences intestinal calcium absorption. Vitamin-K-dependent proteins participate in the handling of minerals in bone and other tissues. Magnesium is also important for bone physiology. These processes interact within the body, but supplement combinations cannot be assumed to prevent calcified arteries, osteoporosis or fractures simply because the pathways interact.

If your interest is in the quality of dietary fat rather than supplement stacking, see our guide to choosing olive oil. A varied diet is a more defensible default than building a universal K2–D3–magnesium protocol from biochemical diagrams.

Who needs extra caution? Warfarin, illness and malabsorption

Vitamin K can interfere seriously with warfarin and similar vitamin-K antagonists. The practical goal for someone taking these drugs is a reasonably consistent intake with clinical INR monitoring, not eliminating leafy vegetables or starting high-dose K2 independently. Major dietary changes and supplements should be discussed with the treating clinician.

Vitamin-K deficiency can arise with impaired fat absorption, some liver or intestinal disorders, prolonged severe dietary restriction or certain medication exposures. Management depends on the cause. The fact sheet below details relevant drug interactions, including selected antibiotics and fat-absorption-inhibiting treatments.

Can a blood test tell whether I need K2?

The original article reported a personal laboratory result of 0.9 ng/mL for circulating phylloquinone (K1), compared with a stated laboratory range of 0.3–2.0 ng/mL. That observation is worth preserving as an anecdote, but it does not measure total body vitamin-K status, K2 exposure or the likely benefit of a K2 supplement. Blood K1 can be influenced by recent intake and lipid transport.

A number inside one lab’s reference interval is not a controlled experiment. Nor does it confirm that extra K2 would alter health outcomes. Clinical assessment of deficiency and bleeding risk is a separate matter.

What remains unresolved

Does MK-7 help people whose diet supplies relatively little K2 but enough total vitamin K? Could particular patients with impaired vitamin-K-dependent protein activation benefit more than healthy adults? Would biomarkers predict clinically meaningful changes in fractures or cardiovascular events? These questions are researchable; broad marketing claims answer them prematurely.

Bottom line: vitamin K is essential, but its essentiality is not a blank cheque for every K2 supplement claim. Eat a varied diet that includes greens; treat the reported AIs as population reference values; and demand clinical outcomes, not just elegant mechanisms, before recommending extra K2.

Primary reference and further reading